@article{387c850b74cb49d5b15e193348bbb68b,
title = "Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information",
keywords = "Acute myeloid leukaemia, Flow cytometry, Fludarabine, Fludarabine, cytarabine, idarubicin, Minimal residual disease",
author = "Paola Minetto and Fabio Guolo and Marino Clavio and Annalisa Kunkl and Nicoletta Colombo and Enrico Carminati and Giuseppina Fugazza and Simona Matarese and Daniela Guardo and Filippo Ballerini and {Di Grazia}, Carmen and Raiola, {Anna M.} and Antonia Cagnetta and Michele Cea and Maurizio Miglino and Lemoli, {Roberto M.} and Marco Gobbi",
year = "2018",
month = jan,
day = "1",
doi = "10.1111/bjh.15106",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
}